Saurabh Saha, M.D., Ph.D., served as Chief Executive Officer of Centessa Pharmaceuticals plc from January 2021 to January 2026 and has advised Centessa since January 2026. He brings over 20 years of experience in health and life sciences.
Before Centessa he was Senior Vice President of R&D and Global Head of Translational Medicine at Bristol Myers Squibb from 2017 to January 2021, and earlier a venture partner at Atlas Venture and President and CEO of Delinia.